Fresenius Medical Care AG & Co. KGaA (FMCQF)
R&D Expenses
€158.47M
TTM · Period ending: · EUR

FMCQF R&D Expenses
What is r&d expenses?
Research and development spending.
FMCQF r&d expenses history
Annual fiscal periods · EUR. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.
| Period ending | R&D Expenses (EUR) | Change |
|---|---|---|
| 157,940,822 | −13.93% | |
| 183,493,000 | −20.90% | |
| 231,970,000 | +1.46% | |
| 228,624,000 | +3.45% | |
| 221,000,000 | +13.92% | |
| 194,000,000 | +15.48% | |
| 168,000,000 | +25.37% | |
| 134,000,000 | +2.29% | |
| 131,000,000 | −14.95% | |
| 154,036,080 | +20.29% | |
| 128,052,400 | +27.63% | |
| 100,327,920 | +10.12% | |
| 91,105,464 | +7.93% | |
| 84,408,664 | −1.29% | |
| 85,513,972 | +17.82% | |
| 72,582,410 | +10.85% | |
| 65,475,627 | +13.60% | |
| 57,638,883 | +26.33% | |
| 45,626,130 | +17.40% | |
| 38,864,193 | −9.66% | |
| 43,021,816 | +13.54% | |
| 37,890,195 | −3.96% | |
| 39,452,968 | −12.72% | |
| 45,202,226 | +12.66% | |
| 40,123,587 | +18.00% | |
| 34,002,471 | +5.32% | |
| 32,286,249 | +21.36% | |
| 26,602,992 | — | |
| 0 | — |
Frequently asked questions: FMCQF r&d expenses
What is Fresenius Medical Care AG & Co. KGaA (FMCQF)'s current r&d expenses?
Fresenius Medical Care AG & Co. KGaA (FMCQF)'s latest reported r&d expenses (TTM) is €158.47M as of Sep 30, 2026. Research and development spending.
How much historical r&d expenses data is available for FMCQF?
Stock Alarm Pro provides 29 dated annual fiscal periods observations for Fresenius Medical Care AG & Co. KGaA (FMCQF)'s r&d expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare FMCQF's r&d expenses to peers or set an alert?
You can open FMCQF's r&d expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on FMCQF delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance